Innovating Works
MYODM-FSMP: New food for special medical purposes to nutritionally manage Myotonic Dystrophy type 1 MYOGEM HEALTH COMPANY tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Myotonic Dystrophy type 1 (DM1) is the most common and multisystemic neuromuscular rare disease affecting 1 million people worldwide, 100,00...
2019-07-15 - 2021-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.